Ameriprise Financial Inc Fulgent Genetics, Inc. Transaction History

Ameriprise Financial Inc

$375 Billion
Q4 2024

A detailed history of Ameriprise Financial Inc transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 501,809 shares of FLGT stock, worth $8.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

501,809

Previous 356,291 40.84%

Holding current value

$8.47 Million

Previous $7.74 Million 19.77%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$16.71 - $22.68 $2.43 Million - $3.3 Million	145,518 Added 40.84%	501,809 $9.27 Million
Q3 2024 Nov 14, 2024	BUY	$19.6 - $25.06 $30,693 - $39,243	1,566 Added 0.44%	356,291 $7.74 Million
Q2 2024 Aug 14, 2024	SELL	$19.09 - $22.57 $103,276 - $122,103	-5,410 Reduced 1.5%	354,725 $6.96 Million
Q1 2024 May 15, 2024	BUY	$21.55 - $29.29 $2.36 Million - $3.21 Million	109,514 Added 43.7%	360,135 $7.81 Million
Q4 2023 Feb 14, 2024	BUY	$23.64 - $30.27 $4.36 Million - $5.58 Million	184,263 Added 277.68%	250,621 $7.25 Million
Q3 2023 Nov 14, 2023	SELL	$26.74 - $40.81 $160,894 - $245,553	-6,017 Reduced 8.31%	66,358 $1.77 Million
Q2 2023 Aug 14, 2023	SELL	$28.52 - $40.7 $126,058 - $179,894	-4,420 Reduced 5.76%	72,375 $2.68 Million
Q1 2023 May 15, 2023	SELL	$29.39 - $36.27 $54,694 - $67,498	-1,861 Reduced 2.37%	76,795 $2.4 Million
Q4 2022 Feb 14, 2023	SELL	$29.23 - $40.28 $229,309 - $315,996	-7,845 Reduced 9.07%	78,656 $2.34 Million
Q3 2022 Nov 14, 2022	SELL	$37.92 - $63.74 $445,749 - $749,263	-11,755 Reduced 11.96%	86,501 $3.3 Million
Q2 2022 Aug 15, 2022	SELL	$47.98 - $62.75 $16,121 - $21,084	-336 Reduced 0.34%	98,256 $5.36 Million
Q1 2022 May 16, 2022	SELL	$49.85 - $96.11 $523,973 - $1.01 Million	-10,511 Reduced 9.63%	98,592 $6.15 Million
Q4 2021 Feb 14, 2022	SELL	$77.3 - $105.0 $1.89 Million - $2.56 Million	-24,390 Reduced 18.27%	109,103 $11 Million
Q3 2021 Nov 15, 2021	BUY	$74.87 - $110.87 $2.63 Million - $3.9 Million	35,181 Added 35.79%	133,493 $12 Million
Q2 2021 Aug 16, 2021	BUY	$66.8 - $100.45 $170,340 - $256,147	2,550 Added 2.66%	98,312 $9.02 Million
Q1 2021 May 17, 2021	BUY	$59.3 - $183.85 $1.92 Million - $5.94 Million	32,296 Added 50.89%	95,762 $9.25 Million
Q4 2020 Feb 12, 2021	BUY	$31.01 - $52.1 $331,838 - $557,522	10,701 Added 20.28%	63,466 $3.31 Million
Q3 2020 Nov 16, 2020	SELL	$15.89 - $50.51 $717,751 - $2.28 Million	-45,170 Reduced 46.12%	52,765 $2.11 Million
Q2 2020 Aug 14, 2020	SELL	$8.89 - $18.28 $262,166 - $539,077	-29,490 Reduced 23.14%	97,935 $1.57 Million
Q1 2020 May 15, 2020	BUY	$6.75 - $19.75 $860,118 - $2.52 Million	127,425 New	127,425 $1.37 Million

Others Institutions Holding FLGT

# of Institutions

207

Shares Held

17.1M

Call Options Held

2.36M

Put Options Held

47.9K

View Full List

About Fulgent Genetics, Inc.

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $511M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

More about FLGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Fulgent Genetics, Inc. Transaction History